Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells

Abstract

Ovarian cancer is highly metastatic with a poor prognosis. The serine/threonine kinase, p70 S6 kinase (p70S6K), which is a downstream effector of phosphatidylinositol 3-kinase/Akt pathway, is frequently activated in ovarian cancer. Here, we show that p70S6K is a critical regulator of the actin cytoskeleton in the acquisition of the metastatic phenotype. This regulation is through two important activities: p70S6K acts as an actin filament cross-linking protein and as a Rho family GTPase-activating protein. Ectopic expression of constitutively active p70S6K in ovarian cancer cells induced a marked reorganization of the actin cytoskeleton and promoted directional cell migration. Using cosedimentation and differential sedimentation assays, p70S6K was found to directly bind to and cross-link actin filaments. Immunofluorescence studies showed p70S6K colocalized with cytochalasin D-sensitive actin at the leading edge of motile cells. The p70S6K did not affect the kinetics of spontaneous actin polymerization, but could stabilize actin filaments by the inhibition of cofilin-induced actin depolymerization. In addition, we showed that p70S6K stimulated the rapid activation of both Rac1 and Cdc42, and their downstream effector p21-activated kinase (PAK1), but not RhoA. Depletion of p70S6K expression or inhibition of its activity resulted in significant inhibition of actin cytoskeleton reorganization and reduced migration, with a concomitant reduction in Rac1, Cdc42 and PAK1 activation, confirming that the effect was p70S6K specific. Similarly, the actin cytoskeleton reorganization/migratory phenotype could be reversed by expression of dominant negative Rac1 and Cdc42, or inhibition of PAK1. These results reveal a new direction for understanding the oncogenic roles of p70S6K in tumor progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, Auersperg N . (2006). Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290: C1532–C1542.

    Article  CAS  Google Scholar 

  • Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK et al. (2004). AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor growth. Oncogene 23: 5853–5857.

    Article  CAS  Google Scholar 

  • Berven LA, Willard FS, Crouch MF . (2004). Role of the p70(S6K) pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res 296: 183–195.

    Article  CAS  Google Scholar 

  • Buick RN, Pullano R, Trent JM . (1985). Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45: 3668–3676.

    CAS  PubMed  Google Scholar 

  • Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J et al. (2006). Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107: 1801–1811.

    Article  CAS  Google Scholar 

  • Chou MM, Blenis J . (1996). The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85: 573–583.

    Article  CAS  Google Scholar 

  • Corps AN, Sowter HM, Smith SK . (1997). Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met. Int J Cancer 73: 151–155.

    Article  CAS  Google Scholar 

  • Dummler B, Ohshiro K, Kumar R, Field J . (2009). Pak protein kinases and their role in cancer. Cancer Metastasis Rev 28: 51–63.

    Article  CAS  Google Scholar 

  • Erickson JW, Cerione RA . (2004). Structural elements, mechanism, and evolutionary convergence of Rho protein-guanine nucleotide exchange factor complexes. Biochemistry 43: 837–842.

    Article  CAS  Google Scholar 

  • Filonenko VV, Tytarenko R, Azatyan SK, Savinskal LO, Gaydar YA, Gout IT et al. (2004). Immunohistochemical analysis of S6K1 and S6K2 localization in human breast tumors. Exp Oncol 26: 294–299.

    PubMed  Google Scholar 

  • Hall A . (1998). Rho GTPases and the actin cytoskeleton. Science 279: 509–514.

    Article  CAS  Google Scholar 

  • Hanein D, Matsudaira P, DeRosier DJ . (1997). Evidence for a conformational change in actin induced by fimbrin (N375) binding. J Cell Biol 139: 387–396.

    Article  CAS  Google Scholar 

  • Holmes GR, Goll DE, Suzuki A, Robson RM, Stromer MH . (1976). Effect of trypsin on rabbit skeletal-muscle alpha-actinin. Biochim Biophys Acta 446: 445–456.

    Article  CAS  Google Scholar 

  • Jefferies HBJ, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G . (1997). Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70(S6k). EMBO J 16: 3693–3704.

    Article  CAS  Google Scholar 

  • Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Thun MJ . (2009). Cancer Statistics, 2009. CA-Cancer J Clin 59: 225–249.

    Article  Google Scholar 

  • Kislauskis EH, Zhu XC, Singer RH . (1994). Sequences responsible for intracellular-localization of beta-actin messenger-RNA also affect cell phenotype. J Cell Biol 127: 441–451.

    Article  CAS  Google Scholar 

  • Latham VM, Kislauskis EH, Singer RH, Ross AF . (1994). Beta-actin messenger-RNA localization is regulated by signal-transduction mechanisms. J Cell Biol 126: 1211–1219.

    Article  CAS  Google Scholar 

  • Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X et al. (2006). Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1 alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 41: 1521–1533.

    Article  CAS  Google Scholar 

  • Nozawa H, Watanabe T, Nagawa H . (2007). Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer. Cancer Lett 251: 105–113.

    Article  CAS  Google Scholar 

  • Olson MF, Ashworth A, Hall A . (1995). An essential role for Rho, Rac and Cdc42 GTPases in cell cycle progression through G1. Science 269: 1270–1272.

    Article  CAS  Google Scholar 

  • Pantaloni D, Le Clainche C, Carlier MF . (2001). Mechanism of actin-based motility. Science 292: 1502–1506.

    Article  CAS  Google Scholar 

  • Pawlak G, Helfman DM . (2001). Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 11: 41–47.

    Article  CAS  Google Scholar 

  • Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH et al. (2001). The phosphatidylinositol 3′-kinase p85 alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61: 7426–7429.

    CAS  Google Scholar 

  • Pon YL, Zhou HY, Cheung ANY, Ngan HYS, Wong AST . (2008). p70 S6 kinase promotes epithelial to mesenchymal transition through Snail induction in ovarian cancer cells. Cancer Res 68: 6524–6532.

    Article  CAS  Google Scholar 

  • Raftopoulou M, Hall A . (2004). Cell migration: Rho GTPases lead the way. Dev Biol 265: 23–32.

    Article  CAS  Google Scholar 

  • Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G et al. (2003). Cell migration: integrating signals from front to back. Science 302: 1704–1709.

    Article  CAS  Google Scholar 

  • Sahin F, Kannangai R, Adegbola O, Wang JZ, Su G, Torbenson M . (2004). mTOR and P70S6 kinase expression in primary liver neoplasms. Clin Cancer Res 10: 8421–8425.

    Article  CAS  Google Scholar 

  • Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F et al. (1998). Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 143: 1385–1398.

    Article  CAS  Google Scholar 

  • Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR et al. (2007). c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res 67: 1670–1679.

    Article  CAS  Google Scholar 

  • Schmidt A, Bickle M, Beck T, Hall MN . (1997). The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 88: 531–542.

    Article  CAS  Google Scholar 

  • Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, Ruffalo T et al. (2003). Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 163: 985–992.

    Article  CAS  Google Scholar 

  • Shayesteh L, Lu YL, Kuo WL, Baldocchi R, Godfrey T, Collins C et al. (1999). PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21: 99–102.

    Article  CAS  Google Scholar 

  • Siu MK, Wong ES, Chan HY, Kong DS, Woo NW, Tam KF et al. (2009). Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Int J Cancer 127: 21–31.

    Article  Google Scholar 

  • Sowter HM, Corps AN, Smith SK . (1999). Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells. Int J Cancer 83: 476–480.

    Article  CAS  Google Scholar 

  • Takaishi K, Sasaki T, Kotani H, Nishioka H, Takai Y . (1997). Regulation of cell-cell adhesion by Rac and Rho small G proteins in MDCK cells. J Cell Biol 139: 1047–1059.

    Article  CAS  Google Scholar 

  • Theriault BL, Shepherd TG, Mujoomdar ML, Nachtigal MW . (2007). BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28: 1153–1162.

    Article  CAS  Google Scholar 

  • Wong AST, Roskelley CD, Pelech S, Miller D, Leung PCK, Auersperg N . (2004). Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. Exp Cell Res 299: 248–256.

    Article  CAS  Google Scholar 

  • Zhou HY, Wong AST . (2006). Activation of p70(S6K) induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology 147: 2557–2566.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr N Auersperg, G Thomas and A Hall for providing cell lines and cDNA constructs. This work was supported by the Research Grant Council grant HKU 7599/05M and the HKU Outstanding Young Research Award (AST Wong).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A S T Wong.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ip, C., Cheung, A., Ngan, H. et al. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 30, 2420–2432 (2011). https://doi.org/10.1038/onc.2010.615

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.615

Keywords

This article is cited by

Search

Quick links